Effects of lobeglitazone on insulin resistance and hepatic steatosis in high-fat diet-fed mice

Lobeglitazone (Lobe) is a novel thiazolidinedione antidiabetic drug that reduces insulin resistance by activating peroxisome proliferator-activated receptor-gamma (PPARγ). However, the exact mechanisms of antidiabetic effects of Lobe have not been established in an animal model. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Bong-Hoi, Jin, Zhen, Yi, Chin-ok, Oh, Juhong, Jeong, Eun Ae, Lee, Jong Youl, Park, Kyung-ah, Kim, Kyung Eun, Lee, Jung Eun, Kim, Hyun-Jin, Hahm, Jong Ryeal, Roh, Gu Seob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034891/
https://www.ncbi.nlm.nih.gov/pubmed/29979770
http://dx.doi.org/10.1371/journal.pone.0200336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034891/
https://www.ncbi.nlm.nih.gov/pubmed/29979770
http://dx.doi.org/10.1371/journal.pone.0200336

Ejemplares similares